Bio-Techne Financial Ratios
NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bio-Techne ratio analysis
Bio-Techne earned a net margin of 15.0% in FY 2026, up from 6.0% a year earlier. Gross margin was 65.8% compared with a median of 66.5% over the prior 9 years. Return on equity reached 8.6%, meaning Bio-Techne generated 0.09 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.09 versus 0.18 the year before, and the current ratio was 4.55. At the end of FY 2026, TECH traded at 61.1 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 11.2 to 129.2, with a median of 49.8. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Bio-Techne financial ratios (annual)
| Ratio | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 61.06 | 115.52 | 68.24 | 46.38 | 53.19 | 129.19 | 11.56 | 21.10 | 11.17 | 14.47 |
| Price / sales | 9.09 | 6.86 | 9.75 | 11.29 | 12.53 | 18.71 | 3.48 | 2.76 | 2.16 | 1.95 |
| Price / book | 5.24 | 4.36 | 5.46 | 6.52 | 8.14 | 11.14 | 1.86 | 1.69 | 1.28 | 1.15 |
| Gross margin | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% | 67.2% | 66.5% |
| Operating margin | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% | 25.5% | 21.3% | 20.5% | 21.2% | 21.4% |
| Net margin | 15.0% | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% | 19.6% | 13.5% |
| Free cash flow margin | 21.7% | 21.0% | 20.4% | 19.0% | 25.4% | 33.1% | 20.8% | 21.9% | 23.2% | 22.8% |
| Return on equity (ROE) | 8.6% | 3.8% | 8.1% | 14.5% | 16.0% | 9.0% | 16.6% | 8.2% | 11.7% | 8.0% |
| Return on assets (ROA) | 7.0% | 2.9% | 6.2% | 10.8% | 11.9% | 6.2% | 11.3% | 5.1% | 7.9% | 4.9% |
| Debt / equity | 0.09 | 0.18 | 0.15 | 0.18 | 0.15 | 0.22 | 0.26 | 0.43 | 0.31 | 0.36 |
| Current ratio | 4.55 | 3.46 | 3.87 | 4.84 | 3.44 | 3.35 | 4.88 | 4.05 | 5.01 | 2.57 |
| Revenue growth | -0.4% | 5.2% | 2.0% | 2.8% | 18.7% | 26.0% | 3.5% | 11.0% | 14.2% | 12.8% |
| EPS growth | 152.2% | -56.2% | -40.3% | 6.0% | 90.8% | -85.1% | 135.6% | -25.4% | 63.1% | -27.5% |